It goes one step further as a triple-agonist, targeting GLP-1, GIP, and glucagon receptors, which may enhance fat metabolism
*FOR ORAL GLP-1 PILLS AS EFFECTIVE AS INJECTABLES SOURCE: National Institutes of Health (NIH), PubMed Central
These include: Nausea Vomiting Diarrhea Constipation Bloating and abdominal discomfort Gastrointestinal Tolerability and Dose Escalation For both tirzepatide and retatrutide, gastrointestinal symptoms are most pronounced during the initial initiation phase and immediately following a dose escalation step
Or not Mounjaro, what is it
The Glucagon Receptor: Your Bodys Hidden Fat Burner Glucagon has been misunderstood in obesity medicine for decades
They are not appropriate for everyone, including people with a personal or family history of medullary thyroid cancer or MEN 2, or during pregnancy